Drug Profile
Loratadine/nortriptyline
Alternative Names: CRx-197; CRx-197 high dose topical cream (0.1% nortriptyline HCl +0.3% loratadine); CRx-197 low dose topical cream (0.1% nortriptyline HCl + 0.1% loratadine); Nortriptyline/loratadine - ZalicusLatest Information Update: 29 Mar 2011
Price :
$50
*
At a glance
- Originator CombinatoRx
- Developer Zalicus
- Class Anti-inflammatories; Antiallergics; Dibenzocycloheptenes; Piperidines; Skin disorder therapies; Tricyclic antidepressants
- Mechanism of Action Cytokine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Plaque psoriasis
Most Recent Events
- 31 Dec 2010 Discontinued - Phase-II for Plaque psoriasis in Germany (Topical)
- 09 Sep 2010 CombinatoRx is now called Zalicus
- 14 Jan 2009 CombinatoRx completes a phase II trial for Plaque psoriasis in Germany (NCT00796211)